Some aspects of the validity of the Montreal Cognitive Assessment (MoCA)for evaluating cognitive impairment in Brazilian patients with Parkinson's disease
Open Access
- 1 December 2016
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 10 (4) , 333-338
Abstract
Background: The Montreal Cognitive Assessment (MoCA) is a short global cognitive scale, and some studies suggest it is useful for evaluating cognition in patients with Parkinson's disease (PD). However, its accuracy has been questioned in studies involving patients with low education. Objective: We sought to assess whether some of the MoCA subtests contribute to the low accuracy of the test. Methods: We performed a cross-sectional retrospective analysis of clinical data in a cohort of 71 patients with PD, most with less than 8 years of education. Patients were examined using the MDS-UPDRS, Hoehn and Yahr and the MoCA. The data were analyzed using mainly descriptive statistics. Results: We analyzed the data of 66 patients that were not demented according to the clinical evaluation and classified them using the proposed cut-off MoCA scores for diagnosis of MCI and dementia. Thirteen patients (19.7%) were classified as having normal cognition, 24 (36.3%) MCI and 29 (43.9%) dementia. Patients with dementia had longer disease duration (p=0.016) and lower education (p=0.0001). Total MoCA scores had a an almost normal distribution with a wide range of scores and only one maximum score. Performance on the MoCA was highly correlated with education (correlation coefficient=0.66, p=0.0001). At least five of the 10 MoCA subtests showed significant floor effects. Conclusion: We believe that some of the MoCA subtests may be too difficult to be completed by PD patients with low educational level, thus contributing to the test's poor diagnostic accuracy.Keywords
This publication has 17 references indexed in Scilit:
- Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-RevisedArquivos de Neuro-Psiquiatria, 2015
- Comparison of the Diagnostic Accuracy of Neuropsychological Tests in Differentiating Alzheimer's Disease from Mild Cognitive Impairment: Can the Montreal Cognitive Assessment Be Better than the Cambridge Cognitive ExaminationDementia and Geriatric Cognitive Disorders Extra, 2014
- Exploring the Utility of the Montreal Cognitive Assessment to Detect HIV-Associated Neurocognitive Disorder: The Challenge and Need for Culturally Valid Screening Tests in South AfricaThe Clinical Neuropsychologist, 2013
- Applicability of the MoCA‐S test in populations with little education in ColombiaInternational Journal of Geriatric Psychiatry, 2012
- Brief screening for mild cognitive impairment: validation of the Brazilian version of the Montreal cognitive assessmentInternational Journal of Geriatric Psychiatry, 2012
- Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson diseaseNeurology, 2009
- The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's diseaseMovement Disorders, 2008
- A comparison of the mini mental state exam to the montreal cognitive assessment in identifying cognitive deficits in Parkinson's diseaseMovement Disorders, 2008
- Clinical diagnostic criteria for dementia associated with Parkinson's diseaseMovement Disorders, 2007
- The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive ImpairmentJournal of the American Geriatrics Society, 2005